MedPath

Danube Pharmaceuticals, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:2
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
1 (100.0%)

Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure

Phase 1
Completed
Conditions
Ocular Hypertension
Elevated IOP
Glaucoma
Interventions
First Posted Date
2008-05-23
Last Posted Date
2009-06-03
Lead Sponsor
Danube Pharmaceuticals, Inc.
Target Recruit Count
54
Registration Number
NCT00683501
Locations
πŸ‡¬πŸ‡§

Omnicare Clinical Research Center, Chippenham, Wiltshire, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.